Use of novel RNA in situ hybridisation (ISH) technology for identification of CD204 and IBA‐1 appeared to have a high specificity and sensitivity in our samples and may be a valuable diagnostic technique in identifying HS. This evidence concerns the gene MSR1 and histiocytic sarcoma.